The first is that HIGD2A is not only highly expressed in tumor tissues but is also strongly expressed in highly proliferative tissues [19], which poses a great challenge for developing HIGD2A-targeted treatment strategy for HCC. The gene discussed is HIGD2A; the disease is hepatocellular carcinoma.